| MR编号 | NL/H/4617/001 |
|---|
| 药品名称 | Aciclovir Accord 25 mg/ml concentrate for solution for infusion |
|---|
| 活性成分 | |
|---|
| 剂型 | Concentrate for solution for infusion |
|---|
| 上市许可持有人 | Accord Healthcare S.L.U. |
|---|
| 参考成员国 - 产品名称 | Netherlands (NL) Aciclovir Accord 25 mg/ml concentraat voor oplossing voor infusie |
|---|
| 互认成员国 - 产品名称 | - Germany (DE)
Aciclovir Accord 25 mg/ml Konzentrat zur Herstellung einer Infusionslösung - Denmark (DK)
- Austria (AT)
Aciclovir Accord 25 mg/ml Konzentrat zur Herstellung einer Infusionslösung - France (FR)
- Spain (ES)
- Portugal (PT)
- Italy (IT)
- Sweden (SE)
- Norway (NO)
Aciclovir Accord - Finland (FI)
- Poland (PL)
Aciclovir Accord - Lithuania (LT)
Aciclovir Accord 25 mg/ml koncentratas infuziniam tirpalui - Estonia (EE)
ACICLOVIR ACCORD - Bulgaria (BG)
Aciclovir Accord - Cyprus (CY)
Aciclovir Accord 25mg/ml Concentrate for solution for infusion - Czechia (CZ)
Aciclovir Accord - Romania (RO)
- Slovenia (SI)
Aciklovir Accord 25 mg/ml koncentrat za raztopino za infundiranje
|
|---|
| 许可日期 | 2020/03/19 |
|---|
| 最近更新日期 | 2024/04/02 |
|---|
| 药物ATC编码 | | 申请类型 | - TypeLevel1：Known Active Substance
- TypeLevel2：Initial Application
- TypeLevel3：Other Generic application Art 10.3 Dir 2001/83/EC
- TypeLevel4：Chemical Substance
- TypeLevel5：Prescription Only
|
|---|
| 附件文件下载 | |
|---|
| 市场状态 | Positive |
|---|
|
|---|